Zhitong Finance App News, Kaisa Health (00876.HK) announced that Qinghai Pharmaceutical Co., Ltd. (Qinghai Pharmaceuticals), a subsidiary of the Group, has successfully obtained the “Drug Registration Certificate” issued by the China National Drug Administration (NDRA) on July 21, 2026, and has been approved for domestic production registration.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Kaisa Health (00876.HK) announced that Qinghai Pharmaceutical Co., Ltd. (Qinghai Pharmaceuticals), a subsidiary of the Group, has successfully obtained the “Drug Registration Certificate” issued by the China National Drug Administration (NDRA) on July 21, 2026, and has been approved for domestic production registration.